Biogen (BIIB) Tops Q1 EPS by 33c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. QQQ
8. LDOS
9. HUM
10. CSCO

Go back to Biogen (BIIB) Tops Q1 EPS by 33c

Biogen Reports First Quarter 2016 Revenues of $2.7 Billion

April 21, 2016 7:15 AM EDT

First quarter 2016 Non-GAAP diluted EPS rise 25%; GAAP diluted EPS rise 27%

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) today reported first quarter 2016 financial results, including:

Total revenues of $2.7 billion, a 7% increase versus the same period in the prior year. Growth was driven by a 15% increase in worldwide TECFIDERA® revenues as well as increased revenues from ELOCTATE® and ALPROLIX®. Revenues were partially offset by a decrease in worldwide interferon sales. Foreign exchange, including a $26 million reduction in hedging gains, negatively impacted total revenues by approximately $50... More